Methylation status of TUSC3 is a prognostic factor in ovarian cancer.

Abstract:

BACKGROUND:Current prognostic information in ovarian cancer is based on tumor stage, tumor grade, and postoperative tumor size. Reliable molecular prognostic markers are scarce. In this article, the authors describe epigenetic events in a frequently deleted region on chromosome 8p22 that influence the expression of tumor suppressor candidate 3 (TUSC3), a putative tumor suppressor gene in ovarian cancer. METHODS:Messenger RNA expression and promoter hypermethylation of TUSC3 were studied in ovarian cancer cell lines and in tumor samples from 2 large, independent ovarian cancer cohorts using polymerase chain reaction-based methods. RESULTS:The results indicated that TUSC3 expression is decreased significantly because of promoter methylation in malignant ovarian tumors compared with benign controls. Almost 33% of ovarian cancer samples had detectable TUSC3 promoter methylation. Furthermore, methylation status of the TUSC3 promoter had a significant and independent influence on progression-free and overall survival. CONCLUSIONS:TUSC3 hypermethylation predicted progression-free and overall survival in ovarian cancer. The current observations suggested a role for N-glycosylating events in ovarian cancer pathogenesis in general and identified the epigenetic silencing of TUSC3 as a prognostic factor in this disease.

journal_name

Cancer

journal_title

Cancer

authors

Pils D,Horak P,Vanhara P,Anees M,Petz M,Alfanz A,Gugerell A,Wittinger M,Gleiss A,Auner V,Tong D,Zeillinger R,Braicu EI,Sehouli J,Krainer M

doi

10.1002/cncr.27850

subject

Has Abstract

pub_date

2013-03-01 00:00:00

pages

946-54

issue

5

eissn

0008-543X

issn

1097-0142

journal_volume

119

pub_type

杂志文章

相关文献

CANCER文献大全
  • Angioimmunoblastic lymphadenopathy: a T-cell deficiency.

    abstract::The case of a 49-year-old man with the diagnosis of angioimmunoblastic lymphadenopathy is reported. The patient survived a stormy clinical course. The corticosteroids improved dramatically the clinical picture although the patient developed a staphylococcal septicemia. Before treatment immunological studies were done ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197808)42:2<447::aid-cncr2820420

    authors: Kosmidis PA,Axelrod AR,Palacas C,Stahl M

    更新日期:1978-08-01 00:00:00

  • Preclinical and clinical studies of interferons and interferon inducers in breast cancer.

    abstract::Preclinical and clinical studies suggest interferons and interferon inducers have antitumor activity for breast carcinoma. Observations include inhibition of growth of freshly derived and continuously passaged breast carcinoma cells in vitro, decreased tumor size and increased survival in spontaneous mouse mammary car...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19840201)53:3+<783::aid-cncr2820

    authors: Borden EC,Balkwill FR

    更新日期:1984-02-01 00:00:00

  • Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.

    abstract:BACKGROUND:LAMP3 is a newly described hypoxia regulated gene of potential interest in hypoxia-induced therapy resistance and metastasis. The prognostic value of LAMP3 in breast cancer was investigated. METHODS:Expression levels of LAMP3 in breast cancer cell lines and patient tissues were determined by real-time polym...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25938

    authors: Nagelkerke A,Mujcic H,Bussink J,Wouters BG,van Laarhoven HW,Sweep FC,Span PN

    更新日期:2011-08-15 00:00:00

  • Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.

    abstract:BACKGROUND:Angiogenesis in individuals with various solid tumors has provided useful information on tumor progression and prognosis, and many examples of mast cell (MC) accumulation coupled with angiogenesis can be found in the literature. METHODS:Utilizing monoclonal antibodies for tryptase that are specific markers ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Takanami I,Takeuchi K,Naruke M

    更新日期:2000-06-15 00:00:00

  • The size of breast masses at presentation. The impact of prior medical training.

    abstract::Five hundred and sixty-nine patients with breast cancer presenting for treatment at a community hospital were studied. The results showed no significant change in tumor size at presentation or reported patient delay over a 12-year span. This was in spite of considerable national discussion and increasing public concer...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830501)51:9<1750::aid-cncr2820

    authors: Buttlar CA,Templeton AC

    更新日期:1983-05-01 00:00:00

  • Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

    abstract::To evaluate the role of chemotherapy in local control of primary breast cancer, the incidence of local failure was evaluated in 768 patients treated with surgery and adjuvant, combination chemotherapy that contained fluorouracil, doxorubicin, and cyclophosphamide (FAC) at our institute between 1974 and 1982. Of these ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900201)65:3<394::aid-cncr28206

    authors: Buzdar AU,McNeese MD,Hortobagyi GN,Smith TL,Kau S,Fraschini G,Hug V,Ellerbroek N,Holmes FA,Ames F

    更新日期:1990-02-01 00:00:00

  • The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines.

    abstract::The National Comprehensive Cancer Network (NCCN) describes the presence of extracapsular spread and/or positive margins in oropharynx cancer (OPC) as an indication for the addition of chemotherapy to postoperative radiation. The guideline's category 1 consensus is based on what they term high-level evidence. For this ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.29242

    authors: Sinha P,Piccirillo JF,Kallogjeri D,Spitznagel EL,Haughey BH

    更新日期:2015-06-01 00:00:00

  • Plasma levels of D-dimer in lung carcinoma: clinical and prognostic significance.

    abstract:BACKGROUND:The activation of the clotting-fibrinolytic system in cancer patients is common and represents an unfavorable clinical sign. D-dimer (DD) is a sensitive marker of fibrinolysis. METHODS:The current study comprised 826 new lung carcinoma patients seen consecutively in a single institution over a 10-year perio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11432

    authors: Buccheri G,Torchio P,Ferrigno D

    更新日期:2003-06-15 00:00:00

  • Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

    abstract:BACKGROUND:Radiofrequency (RF)-induced tissue coagulation represents a new approach for the thermal destruction of tumors within the liver. The purpose of the current study was to 1) assess technique safety; 2) determine the extent and evolution of induced cellular damage; and 3) correlate the observed pathologic effec...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Goldberg SN,Gazelle GS,Compton CC,Mueller PR,Tanabe KK

    更新日期:2000-06-01 00:00:00

  • Quality assurance for interventions in clinical trials. Multicenter data monitoring, data management, and analysis.

    abstract::Quality assurance for the management of multicenter clinical trials requires timely patient and data accrual and consistency with design parameters. Data from central pathology review, treatment modality, and follow-up as well as trial end points direct the selection of appropriate compliance measures. To integrate th...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19941101)74:9+<2647::aid-cncr282

    authors: Pollock BH

    更新日期:1994-11-01 00:00:00

  • Micropapillary serous carcinoma of the ovary: cytomorphologic characteristics in peritoneal/pelvic washings.

    abstract:BACKGROUND:Micropapillary serous carcinoma (MPSC), a recently described entity, is an ovarian tumor with a distinctive histologic architecture that lacks a destructive infiltrative growth pattern and behaves like a low-grade neoplasm. The purpose of this study was to determine if specific cytomorphologic features were ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10619

    authors: Alli PM,Ali SZ

    更新日期:2002-06-25 00:00:00

  • Conditional median survival of patients with advanced carcinoma: surveillance, epidemiology, and end results data.

    abstract:BACKGROUND:Conditional survival is clinically useful, particularly for patients with malignant disease who have a poor prognosis. However, there are no published data on the conditional median survival of patients with advanced carcinoma on a population basis. METHODS:Data on 217,573 patients with breast, colorectal, ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(20011015)92:8<2211::aid-cncr1565

    authors: Kato I,Severson RK,Schwartz AG

    更新日期:2001-10-15 00:00:00

  • Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report.

    abstract::During the period from September, 1976 to June, 1979, 70 patients with locoregional or extensive epidermoid carcinoma of the esophagus were treated with the two-drug combination of cisplatin and bleomycin (DB). For the 43 patients with locoregional disease (LRD), DB was used prior to surgery and/or radiation therapy; ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19841201)54:11<2351::aid-cncr282

    authors: Coonley CJ,Bains M,Hilaris B,Chapman R,Kelsen DP

    更新日期:1984-12-01 00:00:00

  • Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.

    abstract:BACKGROUND:After the introduction of a mammography screening program, the incidence of late-stage breast cancer is expected to decrease. The objective of the current study was to evaluate variations in the total incidence of breast cancer and in the incidence of breast cancers with a pathologic tumor (pT) classificatio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28014

    authors: Foca F,Mancini S,Bucchi L,Puliti D,Zappa M,Naldoni C,Falcini F,Gambino ML,Piffer S,Sanoja Gonzalez ME,Stracci F,Zorzi M,Paci E,IMPACT Working Group.

    更新日期:2013-06-01 00:00:00

  • Evaluation of response criteria in advanced lung cancer.

    abstract::Because we found it illogical to attempt measurement of nonmeasurable but visible tumors in patients with advanced lung cancer, we devised and used a separate set of response criteria for patients with evaluable, nonmeasurable tumors. Patients with evaluable disease who had obtained a tumor regression after therapy we...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197909)44:3<1125::aid-cncr282044

    authors: Eagan RT,Fleming TR,Schoonover V

    更新日期:1979-09-01 00:00:00

  • Oxaliplatin and capecitabine in the treatment of patients with recurrent or refractory carcinoma of unknown primary site: a phase 2 trial of the Sarah Cannon Oncology Research Consortium.

    abstract:BACKGROUND:Despite the widespread use of oxaliplatin-based regimens for colorectal and other gastrointestinal cancers, there is surprisingly little information regarding their empiric use for the treatment of carcinoma of unknown primary site (CUP). In the current study, the combination of oxaliplatin and capecitabine ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.25029

    authors: Hainsworth JD,Spigel DR,Burris HA 3rd,Shipley D,Farley C,Macias-Perez IM,Barton J,Greco FA

    更新日期:2010-05-15 00:00:00

  • Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis.

    abstract:BACKGROUND:The purpose of this study was to determine the independent prognostic variables in a well documented subset of 216 patients with localized primary malignant fibrous histiocytomas (MFH). METHODS:Between the years 1980 and 1989, 216 patients with localized, primary (International Union Against Cancer [UICC]/A...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/(SICI)1097-0142(19960501)77:9<1823::AID-CN

    authors: Le Doussal V,Coindre JM,Leroux A,Hacene K,Terrier P,Bui NB,Bonichon F,Collin F,Mandard AM,Contesso G

    更新日期:1996-05-01 00:00:00

  • Prognostic factors in pediatric spinal cord astrocytoma.

    abstract:BACKGROUND:Factors that could optimize the management of pediatric spinal cord astrocytoma remain unclear and controversial. METHODS:To determine the factors that influence the prognosis of pediatric patients with spinal cord astrocytomas, a series of 73 consecutive patients at 13 French treatment centers with histolo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19981201)83:11<2391::aid-c

    authors: Bouffet E,Pierre-Kahn A,Marchal JC,Jouvet A,Kalifa C,Choux M,Dhellemmes P,Guérin J,Tremoulet M,Mottolese C

    更新日期:1998-12-01 00:00:00

  • Prognostic factors in cervical carcinoma: implications in staging and management.

    abstract::Individualization of treatment using judicious combinations of external and intracavitary irradiation remains the cornerstone of the radiation management of carcinoma of the cervix. The inherent propensity of this cancer to either confine itself to the pelvis or else spread in a systematic and predictable manner throu...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810715)48:1+<560::aid-cncr2820

    authors: Rotman M,John M,Boyce J

    更新日期:1981-07-15 00:00:00

  • HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia.

    abstract:BACKGROUND:Chronic myeloid leukemia (CML) may progress to blast phase (BP) at the rate of 1% to 1.5% per year. With the use of single-agent tyrosine kinase inhibitors, median overall survival ranges between 7 and 11 months. METHODS:The outcome was analyzed for 42 patients with lymphoid BP-CML who were treated with hyp...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28433

    authors: Strati P,Kantarjian H,Thomas D,O'Brien S,Konoplev S,Jorgensen JL,Luthra R,Abruzzo L,Jabbour E,Quintas-Cardama A,Borthakur G,Faderl S,Ravandi F,Cortes J

    更新日期:2014-02-01 00:00:00

  • Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.

    abstract:BACKGROUND:Recently, adenomatous hyperplasia (AH) of the liver, a sizable parenchymal nodule in the cirrhotic liver, has been considered a preneoplastic lesion in human hepatocarcinogenesis. METHODS:The authors evaluated cell proliferative activity by immunostaining for proliferating cell nuclear antigen (PCNA) in AH ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920801)70:3<591::aid-cncr28207

    authors: Terada T,Nakanuma Y

    更新日期:1992-08-01 00:00:00

  • Cardiovascular risk in long-term survivors of testicular cancer.

    abstract:BACKGROUND:Long-term survivors of testicular cancer (TC) who received cisplatin-based chemotherapy have an increased risk of cardiovascular disease. A cross-sectional study was performed to objectively assess cardiovascular risk, subclinical atherosclerosis, and endothelial function in long-term survivors of TC. METHO...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23389

    authors: Vaughn DJ,Palmer SC,Carver JR,Jacobs LA,Mohler ER

    更新日期:2008-05-01 00:00:00

  • Treatment of metastatic breast cancer with aminoglutethimide.

    abstract::Seventy-three women with metastatic breast cancer were treated with aminoglutethimide and dexamethasone. No complete responses occurred. Ten patients (16%) achieved partial responses (mean duration, 12 months). The proportions of patients responding by disease site were breast (50%), nodes (33%), skin (23%), bone (16%...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810415)47:8<1954::aid-cncr2820

    authors: Asbury RF,Bakemeier RF,Fölsch E,McCune CS,Savlov E,Bennett JM

    更新日期:1981-04-15 00:00:00

  • Malignant mesothelioma of the tunica vaginalis testis: report of first case with preoperative diagnosis.

    abstract::The cytologic, histologic and ultrastructural features of a malignant carcinomatous mesothelioma of the tunica vaginalis testis in a 30-year old patient are described. This is the first such case with preoperative diagnosis by cytologic examination of hydrocele fluid and the second with documented history of exposure ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820101)49:1<119::aid-cncr28204

    authors: Japko L,Horta AA,Schreiber K,Mitsudo S,Karwa GL,Singh G,Koss LG

    更新日期:1982-01-01 00:00:00

  • High-risk extracranial chondrosarcoma: long-term results of surgery and radiation therapy.

    abstract:BACKGROUND:A study was undertaken to evaluate results of surgery and radiotherapy (RT) for high-risk extracranial chondrosarcomas. METHODS:Between 1986 and 2006, 60 patients underwent surgery and RT for extracranial high-risk chondrosarcoma. Preoperative RT (median, 50 gray [Gy]) and postoperative RT (median, 60 Gy) w...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25806

    authors: Goda JS,Ferguson PC,O'Sullivan B,Catton CN,Griffin AM,Wunder JS,Bell RS,Kandel RA,Chung PW

    更新日期:2011-06-01 00:00:00

  • Sacituzumab govitecan (IMMU-132), an anti-Trop-2-SN-38 antibody-drug conjugate for the treatment of diverse epithelial cancers: Safety and pharmacokinetics.

    abstract:BACKGROUND:Sacituzumab govitecan (IMMU-132), an antitrophoblastic cell-surface antigen (anti-Trop-2) humanized antibody-SN-38 conjugate, had encouraging efficacy in the phase 1 clinical trial. This report further examines the pharmacokinetics and safety of multiple cycles of IMMU-132 at doses of 8 or 10 mg/kg in patien...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.30789

    authors: Ocean AJ,Starodub AN,Bardia A,Vahdat LT,Isakoff SJ,Guarino M,Messersmith WA,Picozzi VJ,Mayer IA,Wegener WA,Maliakal P,Govindan SV,Sharkey RM,Goldenberg DM

    更新日期:2017-10-01 00:00:00

  • Methotrexate: an active drug in bladder cancer.

    abstract::Forty-nine patients with transitional urothelial tract tumors received methotrexate: 0.5-1.0 mg/kg I.V. Q W (40 patients) or 250 mg/M2 in a 2-hour infusion with citrovorum factor rescue 24 hours later (nine patients). Eleven (26%, 95% confidence limits 13-39%) of 42 patients with bidimensionally measurable metastases ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810315)47:6<1246::aid-cncr2820

    authors: Natale RB,Yagoda A,Watson RC,Whitmore WF,Blumenreich M,Braun DW Jr

    更新日期:1981-03-15 00:00:00

  • Favorable cytogenetic abnormalities in secondary leukemia.

    abstract::The authors report on five patients with secondary leukemia (SL) and one of the "specific" chromosomal rearrangements usually encountered in de novo acute nonlymphoblastic leukemia: inv(16), t(15;17), t(8;21), and t(9;11). They were characterized by solid tumor as the primary malignancy in four of five cases, absence ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890615)63:12<2505::aid-cncr282

    authors: Fenaux P,Lucidarme D,Laï JL,Bauters F

    更新日期:1989-06-15 00:00:00

  • BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma.

    abstract:BACKGROUND:Uterine serous carcinoma (USC) is not recognized as part of any defined hereditary cancer syndrome, and its association with hereditary breast and ovarian carcinoma and Lynch syndrome are uncertain. METHODS:Using targeted capture and massively parallel genomic sequencing, 151 subjects with USC were assessed...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.27720

    authors: Pennington KP,Walsh T,Lee M,Pennil C,Novetsky AP,Agnew KJ,Thornton A,Garcia R,Mutch D,King MC,Goodfellow P,Swisher EM

    更新日期:2013-01-15 00:00:00

  • A renal cell carcinoma neoplastic antigen detectable by immunohistochemistry is defined by a murine monoclonal antibody.

    abstract::BALB/c mice were hyperimmunized with ACHN (ATCC CRL 1611, American Type Culture Collection, Rockville, Maryland), a stable in vitro cell line derived from a malignant pleural effusion in a 22-year-old man with renal cell carcinoma. The hyperimmune spleen cells were fused with NS-1 murine myeloma cells using polyethyle...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870615)59:12<2031::aid-cncr282

    authors: Kochevar J

    更新日期:1987-06-15 00:00:00